Sign In
Buy IRON
$70.35
+2.35 (+3.46%)
At Close: Jun 03, 2026
Disc Medicine, Inc. (NASDAQ:IRON) Given Average Rating of “Moderate Buy” by Brokerages
02:38am, Sunday, 08'th Feb 2026
Disc Medicine, Inc. (NASDAQ: IRON - Get Free Report) has been assigned an average rating of "Moderate Buy" from the thirteen analysts that are currently covering the firm, Marketbeat Ratings reports.
Critical Review: eXoZymes (NASDAQ:EXOZ) vs. Disc Medicine (NASDAQ:IRON)
01:34am, Thursday, 05'th Feb 2026
eXoZymes (NASDAQ: EXOZ - Get Free Report) and Disc Medicine (NASDAQ: IRON - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
01:10pm, Tuesday, 03'rd Feb 2026
NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. (“Disc” or the “Company”) (NASDAQ: IRON). Such investors are
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
10:00am, Thursday, 29'th Jan 2026
NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. ("Disc" or the "Company") (NASDAQ: IRON). Such investors are advised to con
Wall Street Analysts Believe Disc Medicine, Inc. (IRON) Could Rally 48.62%: Here's is How to Trade
10:56am, Wednesday, 28'th Jan 2026
The consensus price target hints at a 48.6% upside potential for Disc Medicine, Inc. (IRON). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnin
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. – IRON
12:33pm, Tuesday, 27'th Jan 2026
NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. (“Disc” or the “Company”) (NASDAQ: IRON). Such investors are adv
Disc Medicine Analyst Remains Confident In Rare Disease Drug Despite FDA Action
01:34pm, Friday, 16'th Jan 2026
The U.S. Food and Drug Administration (FDA) reviewers on Thursday postponed their decision on an experimental treatment from Disc Medicine Inc. (NASDAQ: IRON) by about two weeks to Feb.10.
Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
11:55pm, Wednesday, 14'th Jan 2026
Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer
04:30pm, Monday, 12'th Jan 2026
WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel
Disc Medicine Highlights Recent Achievements and Key Business Objectives and Milestones for 2026
08:30am, Monday, 12'th Jan 2026
WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel
What Investors Should Know About a $511K Disc Medicine Insider Sale and a 26% Stock Run
03:52pm, Sunday, 11'th Jan 2026
The chief legal officer of Disc Medicine sold 6,500 shares of the company for $511,472 on Jan. 2. The sale represented 14.68% of Khara's direct holdings, as reported at the time, reducing his direct o
Disc Medicine (NASDAQ:IRON) Insider Rahul Khara Sells 6,500 Shares
04:51am, Tuesday, 06'th Jan 2026
Disc Medicine, Inc. (NASDAQ: IRON - Get Free Report) insider Rahul Khara sold 6,500 shares of the business's stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an ave
Disc Medicine: RALLY-MF Data Validates Pipeline Optionality
05:37am, Monday, 05'th Jan 2026
Disc Medicine is well-capitalized, with over $800M in cash, ensuring operational runway through 2029 regardless of bitopertin's launch success. Bitopertin's NDA is submitted, aiming for accelerated FD
Insider Selling: Disc Medicine (NASDAQ:IRON) Insider Sells $1,194,343.46 in Stock
04:52am, Friday, 19'th Dec 2025
Disc Medicine, Inc. (NASDAQ: IRON - Get Free Report) insider William Jacob Savage sold 13,093 shares of the company's stock in a transaction dated Monday, December 15th. The shares were sold at an ave
IRON HORSE ACQUISITION II CORP. Announces Pricing of $200 Million Initial Public Offering
05:30pm, Tuesday, 16'th Dec 2025
NEW YORK--(BUSINESS WIRE)--IRON HORSE ACQUISITION II CORP. Announces Pricing of $200 Million Initial Public Offering.
